Literature DB >> 11166676

Toxinological and immunological studies of capillary electrophoresis fractionated Chrysaora quinquecirrha (Desor) fishing tentacle and Chironex fleckeri Southcott nematocyst venoms.

D A Bloom1, F F Radwan, J W Burnett.   

Abstract

Repeated runs of capillary electrophoresis (CE) were used to study partially-purified jellyfish nematocyst venom protein in concentrations sufficient to perform toxinological assays. Nematocyst venoms from Chironex fleckeri (Cf) and Chysaora quinquecirrha were processed. The CE eluate was divided into quadrants by scanning protein content. The fourth fraction of both jellyfish venoms, contained proteins with the smallest molecular weight components, which were responsible for the highest hemolysins and the humoral and cell-mediated immunological activity. Cytotoxic Cf lethal factor activity against human liver cells was widely dispersed throughout both venoms but more prominent in fraction 4. A V(beta) receptor human T-cell repertoire was not species-specific for either crude or fractionated jellyfish nematocyst venom.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166676     DOI: 10.1016/s1532-0456(00)00180-0

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  3 in total

Review 1.  Hemolytic venoms from marine cnidarian jellyfish - an overview.

Authors:  Gian Luigi Mariottini
Journal:  J Venom Res       Date:  2014-07-23

2.  Multigene phylogeny of the scyphozoan jellyfish family Pelagiidae reveals that the common U.S. Atlantic sea nettle comprises two distinct species (Chrysaora quinquecirrha and C. chesapeakei).

Authors:  Keith M Bayha; Allen G Collins; Patrick M Gaffney
Journal:  PeerJ       Date:  2017-10-13       Impact factor: 2.984

3.  Cloning and Expression of N-CFTX-1 Antigen from Chironex fleckeri in Escherichia coli and Determination of Immunogenicity in Mice.

Authors:  Hossein Jafari; Saeid Tamadoni Jahromi; Jamil Zargan; Ehsan Zamani; Reza Ranjbar; Hossein Honari
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.